Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 131 of 200 Β· By data quality, then INN

  1. moroctocog alfa

    REFACTO AF

    EMA: approved

    B02BD02
  2. mosunetuzumab

    LUNSUMIO

    EMA: approved

    L01FX25
  3. moxetumomab pasudotox

    LUMOXITI

    EMA: withdrawn

    L01X
  4. mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10)

    SIILTIBCY

    EMA: approved

    V04CF
  5. nadofaragene firadenovec

    ADSTILADRIN

    EMA: unknown

    L01XL10
  6. naldemedine

    RIZMOIC

    EMA: approved

    A06AH05
  7. nalmefene

    SELINCRO

    EMA: approved

    N07BB05
  8. naloxone

    NALOXONE HYDROCHLORIDE (DBL) Pfizer Australia Pty Ltd

    EMA: approved Β· TGA: approved

    V03AB15
  9. naproxcinod

    BEPRANA

    EMA: application withdrawn

  10. nelfinavir

    VIRACEPT

    EMA: withdrawn

    J05AE04
  11. nemolizumab

    NEMLUVIO

    EMA: approved Β· PMDA: approved

    D11AH12
  12. neratinib

    NERLYNX

    EMA: approved

    L01EH02
  13. nilotinib

    TASIGNA Novartis Pharmaceuticals

    FDA: approved Β· EMA: approved Β· TGA: approved

    L01EA03
  14. nimotuzumab

    THERALOC

    EMA: application withdrawn Β· NMPA: clinical trials

  15. nipocalimab

    IMAAVY

    EMA: approved

    L04AL03
  16. niraparib

    ZEJULA GlaxoSmithKline

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01
  17. nirogacestat

    OGSIVEO

    EMA: approved

    L01XX81
  18. nirsevimab

    BEYFORTUS

    EMA: approved

    J06BD08
  19. nogapendekin alfa inbakicept

    ANKTIVA

    EMA: approved

    L03AC03
  20. nomegestrol

    ZOELY

    EMA: approved

    G03AA14
  21. nomegestrol acetate

    IOA

    EMA: withdrawn

    G03AA14
  22. nonacog alfa

    BENEFIX

    EMA: approved

    B02BD04
  23. nonacog beta pegol

    REFIXIA

    EMA: approved Β· PMDA: approved

    B02BD04
  24. nonacog gamma

    RIXUBIS

    EMA: approved

    B02BD04

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.